BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.610
+0.140 (4.03%)
At close: Apr 2, 2025, 4:00 PM
3.595
-0.015 (-0.42%)
After-hours: Apr 2, 2025, 7:52 PM EDT

BriaCell Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jan '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20 2015 - 2019
Net Income
-11.59-4.79-20.3-26.84-13.82-4.02
Upgrade
Depreciation & Amortization
0.130.080.020.020.020.02
Upgrade
Loss (Gain) on Equity Investments
0.20.11----
Upgrade
Stock-Based Compensation
1.321.82.193.071.970
Upgrade
Other Operating Activities
-15.85-28.38-2.1211.666.360.08
Upgrade
Change in Accounts Receivable
0-0.730.01-0.010.01-0.02
Upgrade
Change in Accounts Payable
1.296.050.660.25-1.412.91
Upgrade
Change in Other Net Operating Assets
2.51.74-4.2-0.63-0.89-0.22
Upgrade
Operating Cash Flow
-21.99-24.13-23.74-12.48-7.75-1.27
Upgrade
Capital Expenditures
-0.46-0.46----
Upgrade
Investment in Securities
-0.38-0.23----
Upgrade
Investing Cash Flow
-0.83-0.68----
Upgrade
Short-Term Debt Issued
----0.220.41
Upgrade
Total Debt Issued
----0.220.41
Upgrade
Short-Term Debt Repaid
-----0.55-0.39
Upgrade
Total Debt Repaid
-----0.55-0.39
Upgrade
Net Debt Issued (Repaid)
-----0.330.02
Upgrade
Issuance of Common Stock
21.64.4246.5165.331.15
Upgrade
Repurchase of Common Stock
---0.05-10.17--
Upgrade
Other Financing Activities
----0.08--
Upgrade
Financing Cash Flow
21.64.423.95-3.74651.17
Upgrade
Foreign Exchange Rate Adjustments
------0.04
Upgrade
Net Cash Flow
-1.23-20.39-19.79-16.2357.25-0.14
Upgrade
Free Cash Flow
-22.45-24.58-23.74-12.48-7.75-1.27
Upgrade
Free Cash Flow Per Share
-13.39-22.41-22.80-12.09-25.72-26.60
Upgrade
Levered Free Cash Flow
-11.42-10.83-15.87-6.86-5.830.21
Upgrade
Unlevered Free Cash Flow
-11.42-10.83-15.87-6.86-5.780.23
Upgrade
Change in Net Working Capital
-4.66-8.573.530.393.45-2.67
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q